Benzodiazepine actions mediated by specific γ-aminobutyric acid(A) receptor subtypes

Nature

Volumn 401, Issue 6755, 1999, Pages 796-800

  Rudolph, Uwe ^a   Crestani, Florence ^a   Benke, Dietmar ^a   Brünig, Ina ^a   Benson, Jack A ^a   Fritschy, Jean Marc ^a   Martin, James R ^b   Bluethmann, Horst ^b   Möhler, Hanns ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE; RECEPTOR SUBTYPE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG TARGETING; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; SYNAPTIC INHIBITION;

ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ARGININE; BENZODIAZEPINES; DIAZEPAM; DRUG DESIGN; GABA MODULATORS; HISTIDINE; HYPNOTICS AND SEDATIVES; MEMORY; MICE; MICE, INBRED C57BL; MUSCLE RELAXANTS, CENTRAL; POINT MUTATION; RECEPTORS, GABA-A;

ANIMALIA; MURINAE;

EID: 0033592682     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/44579     Document Type: Article

References (19)

1. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154-194 (1995).
2. A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291-313 (1998).
3. Mohler, H. & Okada, T. Benzodiazepine receptor, demonstration in the central nervous system. Science 198, 849-851 (1977).
4. Braestrup, C., Albrechtsen, R. & Squires, R. F. High densities of benzodiazepine receptors in human cortical areas. Nature 269, 702-704 (1977).
5. A receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267, 1426-1429 (1992).
6. Kleingoor, C., Wieland, H. A., Korpi, E. R., Seeburg, P. H. & Kettenmann, H. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. Neuroreport 4, 187-190 (1993).
7. A receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett. 431, 400-404 (1998).
8. Fritschy, J.-M. et al. Five subtypes of type A γ-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc. Natl Acad. Sci. USA 89, 6726-6730 (1992).
9. Lakso, M. et al. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl Acad. Sci. USA 93, 5860-5865 (1996).
10. A receptors α4β2γ2 and α6β2γ2. Mol. Pharmacol. 50, 1253-1261 (1996).
11. Bernard, F. et al. in Zolpidem: an Update of its Pharmacological Properties and the Therapeutic Place in the Management of Insomnia (eds Freeman, H., Puech, A. J. & Roth, T.) 21-31 (Elsevier, Paris, 1996).
12. Melchior, C. L. & Allen, P. M. Interaction of pregnanolone and pregnanolone sulfate with ethanol and pentobarbital. Pharmacol. Biochem. Behav. 42, 605-611 (1992).
13. Beuzen, A. & Belzung, C. Link between emotional memory and anxiety states: a study by principal component analysis. Physiol. Behav. 58, 111-118 (1995).
14. Vogel, J. R., Beer, B. & Clody, D. E. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacology 21, 1-7 (1971).
15. Bonetti, E. P. et al. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 78, 8-18 (1982).
16. Hunkeler, W. et al. Selective antagonists of benzodiazepines. Nature 290, 514-516 (1981).
17. Bonetti, E. P. et al. Ro 15-4513: Partial inverse agonism at the BZR and interaction with ethanol. Pharmacol. Biochem. Behav. 31, 733-749 (1988).
18. Misslin, R., Belzung, C. & Vogel, E. Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behav. Proc. 18, 119-132 (1989).
19. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180-185 (1987).